Bill of Lading No.
Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
2021/701/C-2265243
2021-10-29
283529 LABORATORIOS IFA S A JRS CHEMICALS PHARMACEUTICALS FOSFATO DE SODIO MONOBASICO ANHIDRO JRS CHE; Phosphinates (Hypophosphites), Phosphonates (Phosphites) And Phosphates, Polyphosphates, Whether Or Not Chemically Defined, Others
INDIA
BOLIVIA
JAWAHARLAL NEHRU (NHAVA SHEVA)
VERDE
28
KG
25
TAMBOR O BIDON
219
USD
2021/701/C-2265243
2021-10-29
283524 LABORATORIOS IFA S A JRS CHEMICALS PHARMACEUTICALS FOSFATO DE POTASIO DIBASICO USP JRS CHEMICA; Phosphinates (Hypophosphites), Phosphonates (Phosphites) And Phosphates, Polyphosphates, Whether Or Not Chemically Defined, Of Potassium
INDIA
BOLIVIA
JAWAHARLAL NEHRU (NHAVA SHEVA)
VERDE
28
KG
25
TAMBOR O BIDON
219
USD
2021/701/C-2265243
2021-10-29
292529 LABORATORIOS IFA S A JRS CHEMICALS PHARMACEUTICALS CLORHIDRATO DE METFORMINA BP JRS CHEMICALS ; Carboxyimidefunction Compounds (Including Saccharin And Its Salts) And Iminefunction Compounds, Others
INDIA
BOLIVIA
JAWAHARLAL NEHRU (NHAVA SHEVA)
VERDE
883
KG
800
TAMBOR O BIDON
2966
USD
2021/701/C-2333299
2021-12-22
300390 LABORATORIOS IFA S A JRS CHEMICALS PHARMACEUTICALS CRISTALES DE MENTOL USP JRS CHEMICALS / PHARMACEUTICALS; Medicaments (Excluding Goods Of Heading 30.02, 30.05 Or 30.06) Consisting Of Two Or More Constituents Which Have Been Mixed Together For Therapeutic Or Prophylactic Uses, Not Put Up In Measured Doses Or In Forms Or Packings For Retail Sale, For Human Use
INDIA
BOLIVIA
CL-CHILE
VERDE
28
KG
25
CT-CAJA DE CARTON
600
USD
2021/711/C-2209806
2021-09-16
293329 LABORATORIOS IFA S A JRS CHEMICAS PHARMACEUTICALS LANSOPRAZOLE USP JRS CHEMICALS / PHARMACEU; Heterocyclic Compounds With Nitrogen Heteroatom(S) Only, Others
INDIA
BOLIVIA
AHMEDABAD
VERDE
1
KG
1
PIEZA/PAQUETE O TIPOS VARIADOS
345
USD
71221500141063300
2022-01-05
291639 C?NG TY C? PH?N D??C ENLIE IOL CHEMICALS AND PHARMACEUTICALS LTD NLSX drug ibuprofen USP43, 50kg / Drum. (10/2021-09 / 2026). Lot Number: 4002/1201/21 / A-0137B. Reference GPLH number: VD-29623-18.My 100% .NSX: IOL Chemicals and Pharmaceuticals LTD.;NLSX thuốc Ibuprofen USP43, 50kg/Drum.(10/2021-09/2026). Số lô: 4002/1201/21/A-0137B. Số GPLH tham chiếu: VD-29623-18.Mới 100%.NSX: IOL CHEMICALS AND PHARMACEUTICALS LTD.
INDIA
VIETNAM
NHAVA SHEVA
CANG CAT LAI (HCM)
1120
KG
1000
KGM
13900
USD
270422FBLMSGN0422/00430
2022-05-26
291639 C?NG TY C? PH?N D??C PH?M TRUNG ??NG I PHARBACO IOL CHEMICALS AND PHARMACEUTICALS LTD Ibuprofen, USP21 standard; Drug production materials; 100%new; Batchno: 4000/2020/22/A-0172P; Date of manufacturing: 01/2022; SD limit: 12/2026; Manufacturer: Iol Chemicals and Pharmaceuticals Ltd.;Ibuprofen, tiêu chuẩn USP21; nguyên liệu sản xuất thuốc; mới 100%; batchno: 4000/1201/22/A-0172P; ngày sx: 01/2022; hạn sd: 12/2026; nhà sx: IOL Chemicals and Pharmaceuticals Ltd.
INDIA
VIETNAM
NHAVA SHEVA
CANG CAT LAI (HCM)
1120
KG
1000
KGM
10350
USD
2.3102150014e+017
2021-11-12
291639 C?NG TY TNHH LIêN DOANH STELLAPHARM CHI NHáNH 1 IOL CHEMICALS AND PHARMACEUTICALS LTD Raw materials for Tan Pharmaceutical Drugs: IBUPROFEN EP10. Lot: 4001/1101 / 21 / A-2356, 2357. Year SX: 08/2021. Shelf life: 07/2026. TT06 DM7 Section 443;Nguyên liệu sx thuốc tân dược: Ibuprofen EP10. Lô: 4001/1101/21/A-2356, 2357. Năm sx: 08/2021. Hạn dùng: 07/2026. TT06 DM7 mục 443
INDIA
VIETNAM
NHAVA SHEVA
CANG CAT LAI (HCM)
2300
KG
2000
KGM
27200
USD
23251941643
2021-12-13
294111 C?NG TY CP D??C PH?M IMEXPHARM VARTIKA CHEMICALS AND PHARMACEUTICALS PRIVATE LTD Raw materials are pharmaceutical materials for research and testing. Flucloxacillin Sodium (sterile) (BP2021) .Lo: FCS-06210005. NSX: 06 / 21.hd: 05/2024. New 100%. NSX: Vartika Chemicals & Pharmaceutical Ltd;Nguyên liệu là dược chất làm mẫu nghiên cứu, kiểm nghiệm. Flucloxacillin sodium (Sterile) (BP2021) .Lô:FCS-06210005. NSX: 06/21.HD:05/2024. Hàng mới 100%. NSX: Vartika Chemicals &Pharmaceutical LTD
INDIA
VIETNAM
DELHI
HO CHI MINH
14
KG
10
KGM
1400
USD
549212686841
2022-01-25
290721 C?NG TY TNHH RUDOLF LIETZ VIETNAM SOMU CHEMICALS AND PHARMACEUTICALS P LTD Raw materials for producing cosmetics with main components resorcinol: 4-n-butyl resorcinol (2kg / 1 barrel) _ Number CAS: 18979-61-8_With 100%;Nguyên liệu dùng sản xuất mỹ phẩm có thành phần chính Resorcinol: 4-n-BUTYL RESORCINOL (2kg/ 1 thùng)_Số CAS : 18979-61-8_mới 100%
INDIA
VIETNAM
INDIA
HO CHI MINH
4
KG
2
KGM
700
USD
23252221912
2021-12-08
293400 C?NG TY TRáCH NHI?M H?U H?N SINH D??C PH?M HERA UNIQUE CHEMICALS A DIV OF J B CHEMICALS PHARMACEUTICALS LTD Cilnidipine (NL medicine is pharmaceutical to model testing, drug research). STT 213 Catalog 07, Number TT06 / 2018 / TT-BYT in House. Batch No: PCIn410003. NSX: 01/2021. HSD: 12/2025, 100% new goods;CILNIDIPINE (NL làm thuốc là dược chất để làm mẫu kiểm nghiệm, nghiên cứu thuốc). STT 213 danh mục 07 ,số tt06/2018/tt-byt IN HOUSE. BATCH NO: PCIN410003. NSX:01/2021. HSD:12/2025, hàng mới 100%
INDIA
VIETNAM
MUMBAI(EX BOMBAY)
HO CHI MINH
28
KG
25
KGM
92500
USD
067AX28821
2020-12-04
300490 NELPA LIFESCIENCES INC
SWASTIK PHARMACEUTICALS PHARMACEUTICAL PRODUCTS CALMSAPH ALUMINA AND MAGNESIA 31700PCS 317CTNS OTHERS CALMSAPH ALUMINA AND MAGNESIA
INDIA
PHILIPPINES
Port of Manila
Port of Manila
3630
KG
31700
Proof litre
3804
USD
2021/211/C-18672
2021-04-21
300449 FARMEDICAL S R L AAVIS PHARMACEUTICALS MIDAZOLAM FM (MIDAZOLAM 5GM/ML); Medicaments (Excluding Goods Of Heading 30.02, 30.05 Or 30.06) Consisting Of Mixed Or Unmixed Products For Therapeutic Or Prophylatic Uses, Put Up In Measured Doses (Including Those In The Form Of Transdermal Administration System) Or In Forms Or Packings For Retail Sale, For Human Use
INDIA
BOLIVIA
MANDSAUR
VERDE
1116
KG
973
CAJA DE CARTON
88264
USD
MEDUM6054636
2021-02-11
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 9 PALLET CONTAINING 526 CA RTONS PHARMACEUTICALS AS UNDER PRAVASTATIN SODIU M TAB 20MG 90 S NDC CODE:6 8462019690 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S NO.:3004.90.92.20 ANDA NO .:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMICPOTASSIUM CL ER CAPS 10MEQ (750MG) 500 S NDC CODE:68462035705 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.:3004.9 0.92.90 ANDA NO.: 20 2868 T HERAPEUTICE USE: -TREATMEN T OR PREVENTION OF HYPOKAL EMIA 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO.F20087 001593 DT. 07.01.2021 F200 87001594 DT. 07.01.2021 N ET WT: 1008.367 FREIGHT PR EPAID THE TEMPERATURE TO BE SET AT 20 DEGREES CELC IUS IN ACCORDANCE W ITH SHI PPER S INSTRUCTIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1863
KG
9
PKG
0
USD
MEDUMG767350
2020-11-24
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 10 PALLET CONTAINING 457 C ARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAPS 10MEQ (750MG) 100 S NDC C ODE:68462035701 FDA PRODUC T CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AND A NO.:202868 THERAPEUTICE USE: -TREATMENT OR PREVENT ION OF HYPOKALEM
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1997
KG
10
PKG
0
USD
MEDUMV727836
2020-09-18
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 24 PALLETS CONTAINING 408 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3619
KG
24
PKG
0
USD
MEDUMV100604
2020-08-06
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 36 PALLETS CONTAINING 823 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.:3004.90.92.90 AN DA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVE NTION OF HYPOKALE
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6071
KG
36
PKG
0
USD
MEDUMV826000
2020-09-26
651400 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 24 PALLETS CONTAINING 457 CARTONS PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP S 10MEQ (750MG) 100 S NDC CODE:68462035701 FDA PRODU CT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 A NDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREV ENTION OF HYPOKA
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3620
KG
24
PKG
0
USD
MEDUMG224964
2020-10-19
651400 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 10 PALLETS 581 CARTONS PHA RMACEUTICALS AS UNDER POTA SSIUM CL ER CAPS 10MEQ (75 0MG) 500 S NDC CODE:684620 35705 FDA PRODUCT CODE NO. : 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDANO.: 2 02868 THERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA PO
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2130
KG
10
PKG
0
USD
MAEU218449289
2022-06-08
620600 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 14 PALLETS 761 CARTONS PH ARMACEUTICALS AS UNDER ESOM EPRAZOLE MAG DR CAPS 20MG 90 S NDC CODE:68462039090 FDA PR ODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004.90.92 60 A NDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR THE LONG-TERM TREATMENT OF PATHOLOGICAL H YPERSECRETORY CONDITIONS, INC LUDING ZOLLINGER-ELLISON SYN DROME ESOMEPRAZOLE MAG DR C APS 40MG 90 S NDC CODE:684620 39190 FDA PRODUCT CODE NO.: 62 T C C 06 H. T. S NO.: 3004 .90.92 60 ANDA NO.: 209495 THERAPEUTICE USE: ESOMEPRAZOL E MAGNESIUM DELAYED-RELEASE CAPSULES ARE INDICATED FOR T HE LONG-TERM TREATMENT OF PA THOLOGICAL HYPERSECRETORY CO NDITIONS, INCLUDING ZOLLINGER -ELLISON SYNDROME COMMERCI AL & CUSTOM INVOICE NO. F2238 7000139 DT. 29.04.2022 S/BILL NO: 4006221 DT: 29/04/2022 NET WT: 756.17 KGS 14 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3034
KG
14
PKG
0
USD
MEDUMA940102
2021-02-11
624900 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 27 PALLET CONTAINING 808 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC URSODIOL TABS 500MG 100 S NDC C ODE:68462047401 FDA PRODUCT CODE NO.:63 N C A 25 H. T. S NO.:3004.49.00 .10 ANDA NO.: 90-8 01 THER APEUTICE USE: - FOR THE TR EATMENT O F PATIENTS WITH P RIMARY BILIARY CIRRHOSIS T HE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHO SIS 02 DATA LOGGERS HUMI DITY:65% S ET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2005 2004008 DT. 08.01.2021 NE T WT: 5607.01 FREIGHT PR EPAID THE TEMPE RATURE T O BE SET AT +20 DEGREE CEL CIUS IN ACCORDANCE WITH SH IPPER INSTRUCTIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6417
KG
27
PKG
0
USD
KWLD70330040536
2021-02-06
624900 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LTD 01 X 40 RF CNTR TOTAL 41 (FORTY ONE) PACKAGESTS 500MG 500 S NDC CODE68462019005 FDA PRODU CT CODE NO.-62 G C A 49 H. T. S NO.<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8718
KG
41
PKG
0
USD
MAEU216792167
2022-03-24
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 3858 CARTONS PACKED IN 46 PALLETS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC PRAMIPEXOLE TABS 1M G 90 S NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S DI SEASE PRAMIPEXOLE TABS 0.25MG 90 S NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DIS EASE OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AGE NT OLMESARTAN MEDOXOMIL TABLE TS 5MG 30 S NDC CODE:68462043 630 FDA PRODUCT CODE NO.: 62C CA68 H. T. S NO.: 3004.90.922 0 ANDA NO.: 203281 THERAPEUTI CE USE: -TREATMENT OF HYPERTEN SION, ALONE ORWITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S N DC CODE:68462047205 FDA PRODU CT CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA NO. : 206391 THERAPEUTICE USE: - MEDICATION USED FOR HEART FAIL URE, HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART URSODIOL TABS 2 50MG 100 S NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 90-801 THERA PEUTICE USE: - FOR THE TREATME NT OF PATIENTS WITH PRIMARY B ILIARY CIRRHOSIS GABAPENTIN TABLETS 600MG 100 S NDC CODE: 68462012601 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICON VULSANT AGENT NET WT : 10,381 .95 KGS GROSS WT : 12,463.41 KGS COMMERCIAL & CUSTOM INVOI CE NO. F22252005778 DT. 23.02 .2022 F22252005780 DT. 23.02. 2022 SB NO.: 8492215 DT.: 24/ 02/22 SB NO.: 8492102 DT.: 24 /02/22 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12464
KG
46
PKG
0
USD
MAEU216471582
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 49 PACKAGE CONSISTING OF 3295 CARTONS PH ARMACEUTICALS AS UNDER NAPROX EN TABLETS 500MG 100 S NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLET S 25MG 60 S NDC CODE:68462010 860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVULSA NT GABAPENTIN TABLETS 600MG 5 00 S NDC CODE:68462012605 FD A PRODUCT CODE NO: 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.:91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE 03 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO. F222520055 51 DT. 05.02.2022 F2225200555 2 DT. 05.02.2022 F22252005553 DT. 05.02.2022 TOTAL NET.WT. :11610.44KGS SBILL NOS DT. 8053058 07-FEB-2022 80532 61 07-FEB-2022 8053408 07- FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
13478
KG
49
PKG
0
USD
MAEU214106719
2021-11-18
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LTD 1X 40 REEFER FCL 41 PALLETS CONSISTING OF 3143 CARTONS PH ARMACEUTICALS AS UNDER TELMIS ARTAN TABLETS 20MG 30 S NDC C ODE:68462019930 FDA PRODUCT C ODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO. :090032 THERAPEUTICE USE: IN DICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC INDOMETHACIN C APS 25MG 100 S NDC CODE:68462 040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 30 04.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLAM ATORY ROPINIROLE TABS 0.5MG 1 00 S NDC CODE:68462025401 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM OXCARBAZEPINE TABLETS 300MG 100 S NDC CODE:684620 13801 FDA PRODUCT CODE NO. :-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT LITHIUM CA RBONATE CAPS 150MG 100 S NDC CODE:68462022001 FDA PRODUC T CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT LA MOTRIGINE TABLETS FOR OS(CD)25 MG100 S NDC CODE:68462022901 FDA PRODUCT CODE NO.:-61 M C A 38 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:-ANTICONVULSAN T 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200379 1 DT. 22.10.2021 SBILL NO DT 5495765 23.10.20 21 TOTAL GR.WT.:10911.61KGS TOTAL NT.WT.:8849.48KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10911
KG
41
PKG
0
USD
MEDUMA708665
2021-01-28
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 13 PALLET CONTAINING 840 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC TOPIRAMATE TABLETS 25MG 60 S NDCCODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.4 9.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONV ULSANT ZONISAMIDE CAPSULE S 50MG 100 S NDC CODE:6846 2012901 FDA PRODUCT CODE N O.:-61 M C E 44 H. T.S NO .3004.49.00.20 ANDA NO.:-7 7-651 THERAP EUTICE USE:-AN TISEIZURE DRUG 01 DATA LO GGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREESCO MMERCIAL & CUSTOM INVOICE NO. F2005200374 4 DT. 22.12 .2020 NET WT:2,083.02 F REIGHT PREPAID THE TEMP ERATURE TO BE SET AT +20 D E GREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCTION S ON BEHALF OF : GLENMARK PHARMACEUT ICALS LIMITED N AME ACCOUNT : GLENMARK PHA RMACEUTICALS LIMITED<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2550
KG
13
PKG
0
USD
MAEU608910666
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 19 PALLETS CONSISTING OF1600 C ARTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500 MG 500 S NDC CODE: 6846201 9005 FDA PRODUCT CODE NO.: -62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAPSULES 40MG 30 S NDC CODE:68462039730 FD A PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX D ISEASE MUPIROCIN CREAM 2% 15GM NDC CODE: 68462056417 FDA PRODUCT CODE NO.: 61G CJ82 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 201587 THE RAPEUTICE USE: - TOPICAL ANT I-BACTERIAL MUPIROCIN CREAM 2% 30GM NDC CODE: 684620 56435 FDA PRODUCT CODE NO. : 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 20158 7 THERAPEUTICE USE: - TOPI CAL ANTI-BACTERIAL 02 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2225200 5541 DT. 05.02.2022 F2225200 5539 DT. 04.02.2022 TOTAL NE T WT.:3982.30KGS SBILL NO DT. 8023698 06-F EB-2022 8023636 06-FEB- 2022 NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4880
KG
19
PKG
0
USD
MAEU216273001
2022-03-02
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 CONTAINER 19 PALLETS 19 P ALLETS CONSISTING OF 947 CARTO NS 1X40 PART OF FCL REEFER PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 100 S NDC CODE:6846201900 1 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY , ANALGESIC NA PROXEN TABLETS 500MG 500 S NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY, AN ALGESIC PRAMIPEXOLE TABS 1MG 90 S NDC CODE:6 8462033390 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 T HERAPEUTICE USE: USED IN PARKINSON#S DISEASE GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT A GENT 01 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520053 54 DT. 28.01.2022 F2225200535 6 DT. 28.01.2022 SBILL NOS DT. 7836397 29-JAN-20 22 7835871 29-JAN-2022 T OTAL GR.WT.: 6,067.50 KGS TOT AL NT.WT: 5,359.75 KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6067
KG
19
PKG
0
USD
MEDUM6528407
2021-03-13
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 6 PALLET CONTAINING 211 CA RTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 500 S NDCCODE:68462 019005 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC NAPROXEN TABLETS 500MG 5 00 S NDCCODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.9 0.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFL AMMATORY,ANALGESIC NAPROX EN TABLETS 500MG 500 S NDC CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.90.92.40 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY ,ANALGESIC DATA LOGGERS H UMIDITY:65% SET TEMPERATUR E : +20 DEGREES COMMERCIA L & CUSTOM INVOI CE NO. F20 052004434 DT. 06.02.2021 F 20052004437 DT. 06.02.2021 F20052004438 DT. 06.02.2021 NET WT:848.520 FREIGH T PREPAID THE TEM PERATU RE TO BE SET AT +20 DEGREE CELCIUS IN ACCORDANCE WIT H SHIPPER INSTRUCTIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
944
KG
6
PKG
0
USD
MAEU217679575
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PALLETS 97 CARTONS PHAR MACEUTICALS AS UNDER LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO. :206498 THERAPEUTICE USE: -US ED TO TEMPORARILY RELIEVE PA IN AND ITCHING ASSOCIATED WIT H SKIN COMMERCIAL & CUSTOM INVOICE NO. F22252006369 DT. 31.03.2022 NET WT: 908.17 K GS 00 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1065
KG
4
PKG
0
USD
MEDUMA846093
2021-02-08
600700 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 8 PALLET CONTAINING 241 CA RTONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMEN T JAR 5% 50GM NDC CODE:684 62041827 FDA PRODUCT CODE NO.:60Q C J 07 H. T. S NO .:3004.49.00.50 ANDA NO. :2 06498 THERAPEUTICE USE: -U SED TO TEMPORARILY RELIEVE PAIN AND ITCHING ASSOCIAT ED WITHSKIN NAPROXEN TAB LETS 500MG 500 S NDC CODE: 68462019005 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY,ANAL GESIC DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2005 2003888 DT. 30.12.2020 F20 052003893 DT. 31.12.2020 NET WT: 2101.740 FREIGHT P REPAID THE TEMPERATURE TO BE SET AT +20 DEGREE CELC IUS IN ACCORDANCE WITH SHI PPER INSTRUC TIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2380
KG
8
PKG
0
USD
MAEU914132405
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 42 PALLETS 2220 CARTONS P HARMACEUTICALS AS UNDER LIDOC AINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRO DUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AND A NO.:206498 THERAPEUTICE USE : -USED TO TEMPORARILY RELIEV E PAIN AND ITCHING ASSOCIATE D WITH SKIN LIDOCAINE OINTM ENT TUBE 5% 35.44GM NDC CODE: 68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:2064 98 THERAPEUTICE USE: -USED T O TEMPORARILY RELIEVE PAIN AN D ITCHING ASSOCIATED WITH SKI N CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:684620297 92 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.4 0.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. THEOPHYLLINE ER TABS 3 00MG 100 S NDC CODE:684620721 01 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS A RE INDICATED FOR THE TREATME NT OF THE SYMPTOMS AND REVER SIBLE AIRFLOW OBSTRUCTION ASS OCIATED WITH CHRONIC ASTHMA A ND OTHER CHRONIC LUNG DISEASE S, E.G., EMPHYSEMA AND CHRON IC BRONCHITIS LITHIUM CARBO NATE CAPS 300MG 1000 S NDC CO DE:68462022110 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT VERAPAMIL H CL ER TABS 120MG 100S NDC COD E:68462029201 FDA PRODUCT COD E NO.: 62 O C B 13 H. T. S N O.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - A NGINA LITHIUM CARBONATE ER TABS 450MG 100 S NDC CODE:684 62022401 FDA PRODUCT CODE NO. : 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-616 THERAPEUTICE USE: - INDICAT ED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER . BIPOLAR DISORDER, MANIC (D SM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, I N THE OLDER DSM-II TERMINOLOG Y. ALSO INDICATED AS A MAINT ENANCE TREATMENT FOR INDIVIDU ALS WITH A DIAGNOSIS OF BIPO LAR DISORDER. MAINTENANCE THE RAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISH ES THE INTENSITY OF THOSE EPI SODES WHICH MAY OCCUR. VER APAMIL HCL ER TABS 240MG 500 S NDC CODE:68462026005 FDA PR ODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 A NDA NO.:-78-906 THERAPEUTICE USE:-ANGINA OLMESARTAN MED OXOMIL TABLETS 20MG NDC CODE: 68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3 004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - TREATMEN T OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE A GENTS, TO LOWER BLOOD PRESSUR E VERAPAMIL HCL ER TABS 120 MG 100S NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-700 THERAP EUTICE USE: - ANGINA LITHI UM CARBONATE CAPS 300MG 100 S NDC CODE:68462022101 FDA PRO DUCT CODE NO.:-61 N C E 37 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 79 -139 THERAPEUTICE USE:-ANTIMANIC AGENT ZOLM ITRIPTAN TABLETS 5MG 3 S NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO .: 201779 THERAPEUTICE USE: - ANALGESIC/ HUMAN - RX/SINGL E INGREDIENT / PROMPT RELEAS E TABLETS / ZOLMITRIPTAN (ANA LGESIC) COMMERCIAL & CUSTOM I NVOICE NO. F22252006340 DT. 3 1.03.2022 F22252006350 DT. 31 .03.2022 F22252006367 DT. 31. 03.2022 F22252006372 DT. 31.0 3.2022 F22252006377 DT. 31.03 .2022 F22252006380 DT. 31.03. 2022 S/BILL NO: 9496822 DT: 05-APR-22 S/BILL NO: 9496828 DT: 05-APR-22 S/BILL NO: 94 97545 DT: 05-APR-22 S/BILL NO : 9496646 DT: 05-APR-22 S/BI LL NO: 9496820 DT: 05-APR-22 S/BILL NO: 9496826 DT: 05-AP R-22 NET WT: 9,414.21 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11501
KG
42
PKG
0
USD
MAEU216329742
2022-03-02
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 44 PALLET S CONSISTING OF2477 CARTONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004. 49.00.50 ANDA NO.:206498 T HERAPEUTICE USE: -USED TO TE MPORARILY RELIEVE PAIN AND I TCHING ASSOCIATED WITH SKIN OMEPRAZOLE DR CAPSULES 40M G 90 S NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAP EUTICE USE: - TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE VERAPAMIL HCL E R TABS 240MG 500 S NDC CODE: 68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE :-ANGINA TOPIRAMATE TABLET S 50MG 1000 S NDC CODE:68462 015310 FDA PRODUCT CODE NO .:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-AN TICONVULSANT ROPINIROLE TABS 0.25MG 100 S NDC CODE:684 62025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:- TREATMENT OF PARKINSONISM GABAPENTIN TABLETS 800MG 500 S NDC CODE: 68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULS ANT AGENT NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CUS TOM INVOICE NO.& F22252005384 DT. 29.01.2022 F22252005388 DT. 29.01.2022 F22252005397 DT. 29.01.2022 F22252005376 DT. 29.01.2022 F22252005392 DT. 29.01.2022 TOTAL NET W T.:10695.27KGS SB NO & DATE ON BL 7911492 01-FEB-2022 7911445 01-FEB-2022 7911424 01-FEB-2022 7911407 01-FEB -2022 7910960 01-FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12093
KG
44
PKG
0
USD
MAEU218682322
2022-06-22
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 1996 CART ONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT JAR 5% 5 0GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTICE USE: -USED TO TEMPORARILY RE LIEVE PAIN AND ITCHING ASSOC IATED WITH SKIN HEATHER NOR ETHINDRONE 0.35MG 84 NDC CODE :68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO .: 3006.60.00.00 ANDA NO.:90 -454 THERAPEUTICE USE: PREVE NTION OF PREGNANCY. NORETHI NDRONE 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. FELODIPINE ER TABS 2.5MG 100 S NDC CODE: 68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREATME NT OF HYPERTENSION TOPIRAM ATE TABLETS 100MG 1000 S NDC CODE:68462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22352000 718 DT. 26.05.2022 F223520007 19 DT. 26.05.2022 F2235200072 0 DT. 26.05.2022 NET WT: 5 ,794.78 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1684332 DT 26-MAY-2022 S/BIL L NO: 1684334 DT 26-MAY-2022 S/BILL NO: 1684337 DT 26-MAY-2 022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7497
KG
40
PKG
0
USD
MEDUM6393802
2021-03-10
613200 GLENMARK PHARMACEUTICALS INC USA GLENMARK PHARMACEUTICALS LIMITED 1 PALLET CONTAINING 15 C ARTONS PHARMACEUTI CALS AS UNDER APREPITANT CAPSULES 80MG 2UOU NDC CODE:6846205 8458 FDA PRODUCT CODE NO.: 61T C E 32 H. T. S NO.:30 04.90.92.40 ANDA NO. :20777 7 THERAPEUTICE USE:APREPIT ANT IS USEDWITH OTHER MED ICATIONS TO HELP PREVENT N AU SEA AND VOMITING CAUSED BY CANCER DRUG TREATM ENT ( CHEMOTHERAPY). THIS MEDICA TION IS ALSOUSED TO PREVE NT NAUSEA AND VOMITING AFT ER SURGERY.A-EMETIC/NAUSEA NT /HUMAN - RX/SINGLEINGR EDIENT / DELAYED RELEASE T ABLETS /APRE PITANT 1 DATA LOGGERS HUMIDITY:65% COMM ERCI AL & CUSTOM INVOICE NO . F20087001759 DT. 30.01.2 021 NET WT: 0.748 KGS FREIGHT PREPA ID THE TEM PERATURE TO BE SET AT 20 D EGREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCT ION S NAME ACCOUNT :GLENMARK PHARMACEUTICALS LIMITED<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
99
KG
1
PKG
0
USD
MAEU217387974
2022-04-27
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 3 PALLETS 54 CARTONS PHARMACEUTICAL S AS UNDER APREPITANT CAPSU LES 80MG 2UOU NDC CODE:684620 58458 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 T HERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND V OMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). TH IS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EMETIC/NAUS EANT / HUMAN - RX/SINGLE ING REDIENT / DELAYED RELEASE TAB LETS / APREPITANT NITROGLY CERIN SUBLING TABS 0.6MG 100 S NDC CODE:68462064001 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCI AL & CUSTOM INVOICE NO. F2228 7002071 DT. 30.03.2022 S/BILL NO: 4004810 DT: 31.03.2022 NET WT. 12.37 KGS 03 DATA LO GGERS NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
350
KG
3
PKG
0
USD
MAEU913326482
2021-12-02
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 5 P ALLETS CONSISTING OF 408 CARTO NS PHARMACEUTICALS AS UNDER APREPITANT CAPSULES 80MG 6UD NDC CODE:68462058476 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT APREPITANT CAPSULES 125MG 6UD NDC CODE:68462058576 NDC NO.:68462058576 FD A PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 THERAPEUTICE USE:APRE PITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUS ED BY CANCER DRUG TREATMEN T (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMIT ING AFTER SURGERY. A-EMETI C/NAUSEANT / HUMAN - RX/SI NGLE INGREDIENT / DELAYED RELEASE TABLETS / APRE PITANT ROSUVASTATIN TABLET S 10MG 90 S NDC CODE:68462026 290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 079172 THE RAPEUTICE USE: - TO TREAT HIG H CHOLESTEROL AND RELATED CON DITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE 05 DATA LO GGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. F22287001239 DT. 28.10.2021 F22287001277 DT. 01.11.2021 TOTAL GR.WT.:814.99KGS TOTAL NT.WT.:116.20KGS SBILL NO. DT. 4017276 28.10.2021 4017594 01.11.2021<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
815
KG
5
PKG
0
USD